Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Gestational diabetes | Image credit: Phushutter - stock.adobe.com
Questionnaire Evaluates Obstetric Nurse Competency in Managing Gestational Diabetes

May 8th 2025

A validated questionnaire assesses skills, knowledge, and attitudes for effective gestational diabetes management.

Diabetes monitoring | Image credit: abidika - stock.adobe.com
New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

April 23rd 2025

Rural health sign | Image credit: BJP7images - stock.adobe.com
FQHCs Show Low Engagement in Hypertension, Diabetes Trials

April 15th 2025

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com
Housing Instability Linked to Worse Type 2 Diabetes Outcomes

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com
GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

April 9th 2025

More News

FDA Approved | Image credit: chrisdorney – stock.adobe.com
March 6th 2024

FDA Approves First Over-the-Counter Continuous Glucose Monitor

Hayden E. Klein
Starting summer 2024, individuals across the US will be able to purchase a continuous glucose monitor (CGM) without needing a prescription.
AJMC
March 5th 2024

Out-of-Pocket Costs for Diabetes Medications in Employer-Sponsored Health Insurance Plans

Jennie Quach, MBA Cody Midlam, PharmD Chantell Sell, PharmD Jeff Levin-Scherz, MD, MBA
Out-of-pocket costs of diabetes medications other than insulin can be quite high for individuals with employer-sponsored health insurance.
what we're reading logo
February 22nd 2024

What We’re Reading: ACA Perception; FDA Blood Sugar Warning; AI and Physician Burnout

AJMC Staff
More than half of US adults have a favorable view of the Affordable Care Act (ACA); smartwatches and rings that claim to measure blood sugar levels without piercing the skin could be dangerous and should be avoided; many believe artificial intelligence (AI) could be the solution to physician burnout.
Diabetes medicine graphic | Image credit: vectorfusionart stock.adobe.com
February 15th 2024

Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations

Hayden E. Klein
Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Diabetes management may reduce dementia risk | Image credit: Dragana Gordic – stock.adobe.com
February 12th 2024

Primary Care Diabetes Management May Also Reduce Risk of Dementia

Hayden E. Klein
Participants in the Risk Assessment and Management Program-Diabetes Mellitus had reduced risks of developing all-cause dementia by 28%, Alzheimer disease by 15%, vascular dementia by 39%, and other or unspecified dementia by 29%.
Pill bottle with dollars in it | Image credit: Cagkan – stock.adobe.com
February 9th 2024

Lowering Cardiometabolic Drug Costs May Improve Diabetes Health Outcomes

Hayden E. Klein
Patients enrolled in a preventive drug list (PDL) benefit saw an 8.4% reduction in acute, preventable diabetes complication days, and PDL members residing in lower-income areas saw a 10.2% decrease compared with control members.
pregnant woman using insulin pump | Image credit: lukszczepanski – stock.adobe.com
February 8th 2024

Diabetes Management During Pregnancy: Insights From 3 Specialists

Hayden E. Klein Laura Joszt, MA
Experts explain how diabetes is diagnosed during pregnancy, how treatment differs from that of nonpregnant individuals, the importance of diabetes technology education, and how things change postpartum.
COVID-19 | Image Credit: Production Perig - stock.adobe.com
February 1st 2024

Review: COVID-19 Pandemic Impact on Clinical Outcomes in Patients With Diabetes

Brooke McCormick
This systematic review found COVID-19 disruptions on clinical outcomes in those with diabetes to be more pronounced for females, younger people, and those a part of racial and ethnic minority groups.
Pharmacists conversing | Image credit: Gorodenkoff – stock.adobe.com
January 27th 2024

Impact of a Pharmacist-Managed TOC Clinic on Diabetes Outcomes Following Hospitalization

Hayden E. Klein
While the clinic did not significantly reduce hospital readmission rates for patients with diabetes, it was able to decrease the time to follow-up and improve long-term diabetes outcomes following hospitalization.
The Americas | Image credit: Віталій Баріда – stock.adobe.com
January 25th 2024

Diabetes Mortality Trends Were Stable in the Americas Over 20-Year Period

Hayden E. Klein
An analysis covered trends in mortality caused by diabetes and diabetic kidney disease across North, South, and Central America from 2000 to 2019.
HbA1c test | Image credit: jarun011 – stock.adobe.com
January 23rd 2024

HbA1c Above 6% Linked to Much Greater Diabetes Risk in Adolescents

Hayden E. Klein
Compared with a hemoglobin A1c (HbA1c) level of 5.5%, adolescents with overweight or obesity were 72 times more likely to have diabetes if their HbA1c was 6.3% to 6.4%.
Ian Neeland, MD
January 11th 2024

What Happens to Patients With Diabetes When Semaglutide Dosing Is Disrupted? Dr Ian Neeland Explains

Hayden E. Klein
Possible long-term consequences for patients with diabetes forced to switch to alternative medications during the semaglutide shortage include the risk of losing ground in glycemic control, having uncontrolled diabetes with associated symptoms, and other adverse events.
the top 5 videos of 2023
December 28th 2023

Top 5 Most-Viewed Videos of 2023

Hayden E. Klein
Our most-viewed videos include interviews about a type 2 diabetes reversal program with impressive 6-month results, concerns over service denials in certain health plans, the Enhancing Oncology Model, and more.
the top 5 diabetes articles of 2023
December 19th 2023

Top 5 Diabetes Articles of 2023

Hayden E. Klein
Our most-read articles on diabetes covered racial biases in type 2 diabetes risk prediction models, cardiovascular disease as a leading cause of hospital admissions in patients with diabetes, and much more.
highlights from kidney week 2023
December 13th 2023

ICYMI: Highlights From Kidney Week 2023

Hayden E. Klein
Our most-read coverage of American Society of Nephrology Kidney Week 2023 highlighted discussions on the challenges of medication dose adjustments in chronic kidney disease, the impact of LGBTQ+ health care disparities on kidney outcomes, and much more.
Metformin | Image credit: Sherry Young – stock.adobe.com
December 12th 2023

Metformin Does Not Improve Neonatal Outcomes for Pregnant Patients With Diabetes

Hayden E. Klein
Adding metformin to the insulin regimen for pregnant patients with preexisting type 2 diabetes (T2D) or gestational diabetes diagnosed early in pregnancy did not reduce the risk of neonatal adverse outcomes.
AJMC
December 12th 2023

Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes

David T. Liss, PhD Manisha Cherupally, MS Matthew J. O’Brien, MD, MSc Raymond H. Kang, MA Cassandra Aikman, MPH Amisha Wallia, MD, MS Andrew J. Cooper, MSc Eleena Koep, MS Emily D. Parker, PhD, MPH Ronald T. Ackermann, MD, MPH
Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Woman having telemedicine visit on tablet | Image credit: rh2010 – stock.adobe.com
December 6th 2023

Exclusive Telemedicine Use Linked to Less Favorable Glycemic Outcomes for T2D Endocrinology Care

Hayden E. Klein
Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using in-person care or a mix of both.
Filling out form | Image credit: Tomasz Papuga – stock.adobe.com
November 29th 2023

Research Points to Potential MCIDs in Diabetes Distress Scale–17

Hayden E. Klein
Researchers identified a value of at least 0.25 to be a minimal clinically important difference (MCID) in diabetes distress, and MCID values of 0.38 and 0.39 for emotional and interpersonal distress subscales and physician and regimen distress subscales, respectively.
Chase D. Hendrickson, MD, MPH
November 21st 2023

Dr Chase Hendrickson Explains Reasons Behind Varying CGM Uptake in Endocrinology, Primary Care Settings

Hayden E. Klein
Chase Hendrickson, MD, MPH, Vanderbilt University Medical Center, attributes gaps in continuous glucose monitoring (CGM) prescribing rates to patient demographics, endocrinologists' longer familiarity with the technology, and the availability of ancillary support in endocrine clinics.
Colorectal screening | Image credit: Richelle – stock.adobe.com
November 14th 2023

Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D

Hayden E. Klein
The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Red FDA approved stamp
November 8th 2023

FDA Approves Diabetes Drug Tirzepatide for Chronic Weight Management

Laura Joszt, MA
Tirzepatide is already approved to treat type 2 diabetes, and is now approved for chronic weight management in adults with obesity or overweight with at least 1 weight-related condition.
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
November 8th 2023

Biomarkers of Kidney Disease Progression Have “Transcendent Signals” Across Subtypes, Says Dr Steven Coca

Laura Joszt, MA Gillian McGovern
Regardless of kidney disease subtype, biomarkers can successfully ascertain risk of kidney disease progression, said Steven Coca, DO, MS, of the Icahn School of Medicine at Mount Sinai.
AJMC
November 2nd 2023

Charitable Medication Distribution Improves Care for Uninsured Patients With Diabetes

Jonathan Hughes, PharmD, BCPS, BCACP Abby Sparkman, PharmD Priscilla Smith, PharmD, BS, BCPPS Tim McCormack, PharmD, BCPS Tavajay Campbell, PharmD, BCACP Hillary Blackburn, PharmD, MBA
This report illustrates how providing vital diabetes medications to uninsured patients through a charitable medication distributor improves clinical outcomes.
AJMC
October 31st 2023

At-Home Hemoglobin A1c Testing During COVID-19 Improved Glycemic Control

Lauren C. LaMonica, MPH Jingwei Ren, MS Nina Jain, MD Eli S. Goldberg, PhD Kyu B. Rhee, MD Paige Wickner, MD Sreekanth K. Chaguturu, MD
Providing at-home hemoglobin A1c test kits increases testing rates and facilitates hemoglobin A1c reduction over time among members of a large commercial health plan with diabetes.
AJMC
October 31st 2023

Safety vs Price in the Generic Drug Market: Metformin

Ben Teasdale, MPhil Amber Hudspeth, MS Kaury Kucera, PhD David Light, BS Jill Nailor, RPh Shannon Williams, BS Arnold Milstein, MD Kevin A. Schulman, MD
The generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. The authors examine price and quality after these recalls.
US and Mexico flags | Image Credit: Rawf8 – stock.adobe.com
October 25th 2023

How Can Family Affect Diabetes Management in Mexican American Adults?

Hayden E. Klein
Interviews highlight the importance of culturally-tailored diabetes education to address health care disparities in the Mexican American community.
Steak on cutting board | Image Credit: Rishieka – stock.adobe.com
October 20th 2023

High Red Meat Consumption Linked to Increased Diabetes Risk

Hayden E. Klein
New research found that people who routinely eat high amounts of red meat have a 62% higher risk of developing type 2 diabetes, supporting dietary recommendations to limit red meat consumption.
AJMC
October 19th 2023

Use of Second-Generation Antidiabetic Medication Among a Nationally Representative Sample

Bang Truong, PhD Yuexin Li, MS Jingyi Zheng, PhD Jingjing Qian, PhD
Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer antidiabetic agents.
What We’re Reading: Alzheimer Blood Tests; Year-Long Adderall Shortage; Type 2 Diabetes Management
October 12th 2023

What We’re Reading: Alzheimer Blood Tests; Year-Long Adderall Shortage; Type 2 Diabetes Management

AJMC Staff
Blood tests offer a less invasive and more accessible means of detecting Alzheimer disease; Democrats address a year-long Adderall shortage; A new study shows significantly improved clinical outcomes in Type 2 diabetes management with a digital behavioral therapy app.
<12345678
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo